Dermorphin
Animal studies onlyGet notified when the evidence changes.
Almost all the research is in animals. We do not know if the same thing happens in people.
Compiled and reviewed by the PeptideSearch Editorial Team · Status checked 2026-08-04
A strong pain-blocking peptide first found in frog skin. Animal research only.
The basics
- What is it?
- Dermorphin is a natural opioid peptide from South American tree frogs. It is far more potent than morphine in animals and is banned in horse racing. There is no approved human use.
Official status: Not nominated for 503A compounding · Checked 2026-08-04
Can a doctor prescribe this?
- Small pharmacy (503A)
- Never put forward to FDA
- Large outsourcing facility (503B)
- Never put forward to FDA
Not FDA approved and not on the U.S. compounding list. A doctor cannot prescribe it.
503A is a pharmacy making a single prescription for one patient. 503B is a facility making batches. They are governed by separate lists. Where a category is shown, it is a position on the FDA's list of substances that have been put forward and are still being worked through — not the final list, which is set by rulemaking. Category 1 means the FDA does not plan to act against a pharmacy that makes it while the review runs.
Lab suppliers we list: 2
Doses used in research
Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.
- Study in peopleIntrathecal dermorphine in postoperative analgesia.
Peptides · 1985
- Data from people, not a trialShamanic Kambô Frog Hyponatremic Toxicity Leading to Brain Death: A Case Report.
Cureus · 2025
- Animal study, rats or micePersistent Headache and Pain Sensitization After Traumatic Brain Injury Is Driven by Mu-Opioid Receptor-Positive Neurons in The Rostral Ventromedial Medulla for both Males and Females
2026
- Animal study, rats or miceDifferential opioid receptor expression and biochemical coupling profiles on glia.
Biochemical pharmacology · 2026
- Animal study, rats or miceDermorphin blocks apneic response to intravenous bolus injection of fentanyl.
Toxicology and applied pharmacology · 2026
- Animal study, rats or miceCharacterizing a new rat model of chronic pain after spine surgery.
Bone research · 2025
- Animal study, rats or miceRespiratory and Cardiovascular Activity of LENART01, an Analgesic Dermorphin-Ranatensin Hybrid Peptide, in Anesthetized Rats.
International journal of molecular sciences · 2025
- Animal study, rats or miceDermorphin [D-Arg2, Lys4] (1-4) Amide Attenuates Burn Pain by Inhibiting TRPV1/NR2B Mediated Neuroinflammatory Signalling.
Molecular neurobiology · 2025
- Animal study, rats or miceDermorphin [D-Arg2, Lys4] (1-4) Amide Alleviates Frostbite-Induced Pain by Regulating TRP Channel-Mediated Microglial Activation and Neuroinflammation.
Molecular neurobiology · 2024
- Animal study, rats or micePeripheral mu-opioid receptor activation by dermorphin [D-Arg2, Lys4] (1-4) amide alleviates behavioral and neurobiological aberrations in rat model of chemotherapy-induced neuropathic pain.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
- Animal study, rats or miceMu opioid receptor expressing neurons in the rostral ventromedial medulla are the source of mechanical hypersensitivity induced by repeated restraint stress.
Brain research · 2023
- Animal study, rats or miceIntracerebroventricular Administration of Dermorphin-Dynorphin Analogs Producing Antidepressant-Like Effects through Activation of μ<sub>1</sub>- and κ-Opioid Receptors in Mice.
Biological & pharmaceutical bulletin · 2022
- Animal study, rats or miceEvaluation of Dermorphin Metabolism Using Zebrafish Water Tank Model and Human Liver Microsomes.
Current drug metabolism · 2021
- Animal study, rats or miceRegular physical activity reduces the percentage of spinally projecting neurons that express mu-opioid receptors from the RVM
2020
- Animal study, rats or miceRegular physical activity reduces the percentage of spinally projecting neurons that express mu-opioid receptors from the rostral ventromedial medulla in mice.
Pain reports · 2020
- Lab dish studyThe Neurotropic Activity of Novel Dermorphin Analogs Active at Systemic and Noninvasive Administration.
International journal of molecular sciences · 2025
- Lab dish studyIn Vitro and In Vivo Pharmacological Profiles of LENART01, a Dermorphin-Ranatensin Hybrid Peptide.
International journal of molecular sciences · 2024
- Lab dish studyPharmacokinetic profile of the synthetic mu-opioid receptor agonist [Lys7]Dermorphin-IRDye®800CW and its feasibility as a biomarker for opioid use disorder
2023
- Lab dish studyIn vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl.
Neuropharmacology · 2022
- Lab test method, not a health studyElucidating important factors and corresponding method optimization for sensitive detection of small peptide drugs in human urine by solid-phase extraction and UPLC-HRMS: The influence of MS scan modes, protein precipitants, and ammonium formate.
Drug testing and analysis · 2025
- Lab test method, not a health studyIdentification of the dermorphin tetrapeptide [Dmt<sup>1</sup> ]-DALDA in a seized unlabelled vial and its first detection in horse urine: A case report.
Drug testing and analysis · 2024
- Lab test method, not a health studyA high throughput approach for determination of dermorphin in human urine using liquid chromatography-mass spectrometry for doping control purposes.
Journal of mass spectrometry : JMS · 2020
- Lab test method, not a health studyIdentification of ex vivo catabolites of peptides with doping potential in equine plasma by HILIC-HRMS.
Drug testing and analysis · 2020
- Biomimetic Dual-Target Theranostic Nanovaccine Enables Magnetic Resonance Imaging and Chemo/Chemodynamic/Immune Therapy of Glioma.
ACS applied materials & interfaces · 2024
- Evaluation of Antimicrobial Activities against Various <i>E. coli</i> Strains of a Novel Hybrid Peptide-LENART01.
Molecules (Basel, Switzerland) · 2023
- MOP and NOP receptor interaction: Studies with a dual expression system and bivalent peptide ligands.
PloS one · 2022
- Evaluation of [Cys(ATTO 488)8]Dermorphin-NH2 as a novel tool for the study of μ-opioid peptide receptors.
PloS one · 2021
- Prolactin-releasing activity of dermorphin, a new synthetic potent opiate-like peptide, in normal human subjects.
The Journal of clinical endocrinology and metabolism · 1983
Spot an error? corrections@peptidesearch.org